You just read:

L.E.A.F. Pharmaceuticals Receives Positive US FDA Feedback and Comprehensive Roadmap for Clinical Development as well as Registration of its Four Lead Novel Anticancer Drugs

News provided by

L.E.A.F. Pharmaceuticals LLC

Oct 29, 2018, 17:27 ET